<?xml version="1.0" encoding="utf-8"?><!--Generated by Screaming Frog SEO Spider 19.2-->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.delixtherapeutics.com/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/publications/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/policy/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/history/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/pipeline/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/mission/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/psychoplastogens/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/investors/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/science/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/terms/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/retsina/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/pranay-srivastava/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/delix-therapeutics-appoints-aaron-koenig-md-as-chief-medical-officer/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/dan/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/delix-therapeutics-expands-world-class-team-with-first-head-of-rd/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/michael-bower-phd/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/rajiv/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/kurt/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/nature-biotechnology-selects-delix-therapeutics-as-a-leading-biotech-start-up/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/pioneering-delix-therapeutics-study-published-in-science-elucidates-the-mechanism-of-psychedelic-induced-neuroplasticity/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/aaron/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/nature-biotechnologys-academic-spinouts-2021/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/prescott/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/paul/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/nick-pelletier-mba/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/alison/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/colin/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/delix-therapeutics-announces-completion-of-1st-cohort-dosing-dose-escalation-approval-in-phase-i-trial-for-novel-compound-dlx-001/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/eliseo/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/the-galien-foundation-announces-2023-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/david/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/robin-prince-phd/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/tricia/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/mark/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/becca/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/andrew/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/lisa/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/matt/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/delix-therapeutics-partners-with-cellectricon-expressive-neuroscience-and-expands-science-team-to-accelerate-drug-discovery-and-translatability/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/liegh/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/delix-therapeutics-and-pfizer-uk-recognized-as-gender-equity-champions-for-women-in-the-workplace-by-healthcare-businesswomens-association/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/news/delix-therapeutics-initiates-phase-i-trial-for-novel-compound-dlx-001/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.delixtherapeutics.com/leadership/milan/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/history/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/publications/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/mission/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/pipeline/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/psychoplastogens/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/science/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/policy/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/terms/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/investors/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/aaron/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/david/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/andrew/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/robin-prince-phd/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/nature-biotechnology-selects-delix-therapeutics-as-a-leading-biotech-start-up/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/eliseo/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/becca/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/tricia/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/delix-therapeutics-and-pfizer-uk-recognized-as-gender-equity-champions-for-women-in-the-workplace-by-healthcare-businesswomens-association/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/prescott/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/delix-therapeutics-announces-completion-of-1st-cohort-dosing-dose-escalation-approval-in-phase-i-trial-for-novel-compound-dlx-001/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/milan/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/delix-therapeutics-expands-world-class-team-with-first-head-of-rd/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/michael-bower-phd/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/pioneering-delix-therapeutics-study-published-in-science-elucidates-the-mechanism-of-psychedelic-induced-neuroplasticity/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/retsina/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/kurt/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/lisa/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/colin/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/liegh/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/nick-pelletier-mba/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/delix-therapeutics-initiates-phase-i-trial-for-novel-compound-dlx-001/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/the-galien-foundation-announces-2023-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/matt/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/delix-therapeutics-partners-with-cellectricon-expressive-neuroscience-and-expands-science-team-to-accelerate-drug-discovery-and-translatability/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/nature-biotechnologys-academic-spinouts-2021/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/paul/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/mark/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/dan/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/pranay-srivastava/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/news/delix-therapeutics-appoints-aaron-koenig-md-as-chief-medical-officer/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/rajiv/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://delixtherapeutics.com/leadership/alison/</loc>
    <lastmod>2023-11-10</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
</urlset>